These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1880 related articles for article (PubMed ID: 18568549)

  • 1. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
    Kim CK; Park BK; Lee HM
    J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK; Park BK; Lee HM; Kwon GY
    Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
    Kitajima K; Kaji Y; Fukabori Y; Yoshida K; Suganuma N; Sugimura K
    J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results.
    Kim CK; Choi D; Park BK; Kwon GY; Lim HK
    J Magn Reson Imaging; 2008 Oct; 28(4):963-9. PubMed ID: 18821631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
    Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
    AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of diffusion-weighted imaging in the localization of prostate cancer.
    Kajihara H; Hayashida Y; Murakami R; Katahira K; Nishimura R; Hamada Y; Kitani K; Kitaoka M; Suzuki Y; Kitajima M; Hirai T; Morishita S; Awai K; Yamashita Y
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):399-403. PubMed ID: 19019564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of diffusion-weighted MRI for prostate cancer detection and localization.
    Yağci AB; Ozari N; Aybek Z; Düzcan E
    Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
    J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection.
    Morgan VA; Kyriazi S; Ashley SE; DeSouza NM
    Acta Radiol; 2007 Jul; 48(6):695-703. PubMed ID: 17611881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of MRS and DWI in the diagnosis of prostate cancer based on sextant analysis.
    Li B; Cai W; Lv D; Guo X; Zhang J; Wang X; Fang J
    J Magn Reson Imaging; 2013 Jan; 37(1):194-200. PubMed ID: 23002033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
    Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
    Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging.
    Miao H; Fukatsu H; Ishigaki T
    Eur J Radiol; 2007 Feb; 61(2):297-302. PubMed ID: 17085002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
    Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
    Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization.
    Rosenkrantz AB; Mannelli L; Kong X; Niver BE; Berkman DS; Babb JS; Melamed J; Taneja SS
    J Magn Reson Imaging; 2011 Jul; 34(1):95-100. PubMed ID: 21698707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 94.